When was Oncotherapeutics founded?

Oncotherapeutics was founded in 1988 and raised its 1st funding round 5 years after it was founded.

Where is Oncotherapeutics located?

Oncotherapeutics is headquartered in West Hollywood, United States.

How many employees does Oncotherapeutics have?

As of Mar 31, 2026, the latest employee count at Oncotherapeutics is 12.

Is Oncotherapeutics an acquired company?

Oncotherapeutics got acquired by undefined on Sep 04, 1995.

Is Oncotherapeutics a funded company?

Oncotherapeutics is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jun 1993.

When was the latest funding round of Oncotherapeutics?

Oncotherapeutics' latest funding was a $***** Series A round on Jun 1993, with participation from 2 investors.

Where does Oncotherapeutics rank among its competitors?

Oncotherapeutics ranks 5th amongst 105 active competitors, of which 14 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Tharimmune, which secured $545M in Nov, 2025.

Who are the top competitors of Oncotherapeutics?

Oncotherapeutics' top competitors include OnCusp, CancerVax and Linical. Among them, Tharimmune secured the most recent funding round in November, 2025.

Oncotherapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

CRO focused on community oncology research, improving cancer therapies' clinical utility. We are a strategic contract research organization dedicated to advancing cancer care through community-based hematology and oncology research sites. We provide real-world experience, data, and outcomes to improve the clinical utility of cancer therapies and patient lives. Our personalized service portfolio supports preclinical research and clinical trials. We accelerate study startup, patient enrollment, and deliver strategic resources for superior results, treatment innovation, and optimization. We focus on community oncologists, providing customer service, transparency, and solutions-oriented communications. We strive to be a transformative organization, leading to advanced drug development initiatives. Our services include program strategy, clinical operations, data management, and medical writing. We build strong relationships, foster innovation, and deliver value to extend the lives of cancer patients.

Website: oncotherapeutics.com
Social
Email ID: *****@oncotherapeutics.com
Phone Number: +1 **********

Key Metrics

Founded Year

1988

Location

West Hollywood, United States

Stage

Acquired

Total Funding

$8.3M in 1 round

Latest Funding Round

Series A, Jun 1993, $*****

Investors

Domain Associates & 1 more

Ranked

5^th among 105 active competitors

Employee Count

12 as on Mar 31, 2026

Similar Companies

OnCusp & 117 more

Exit Details

Acquired

View Oncotherapeutics' full profile

Oncotherapeutics got acquired by on Sep 04, 1995.

Click here to take a look at Oncotherapeutics's acquisition in detail

Oncotherapeutics has raised a total funding of $8.3M over 1 round. Its latest funding round was a Series A round on Jun 1993 for $*****. 2 investors participated in its latest round. Oncotherapeutics has 2 institutional investors.

Here is the list of recent funding rounds of Oncotherapeutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 1993	5302728	Series A	3812278	3168850	6556037	6351623

Access funding benchmarks and valuations. Sign up today!

View details of Oncotherapeutics's funding rounds and investors

Oncotherapeutics' employee count trend

Oncotherapeutics has 12 employees as of Mar 26. Here is Oncotherapeutics's employee count trend over the years:

Employee count trend for Oncotherapeutics

Uncover Oncotherapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oncotherapeutics include OnCusp, CancerVax and Linical. Here is the list of Top 10 competitors of Oncotherapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OnCusp 2021, New York City (United States), Series A	CRO offering clinical development services for oncology drugs	$139M	Orbimed, F-Prime Capital & 8 others	55/100
2nd	CancerVax 1998, Carlsbad (United States), Series B	Limited information available	$58M	Athenian Venture Partners, endpointgroup.com ... & 11 others	50/100
3rd	Linical 2005, Osaka (Japan), Public	Full service CRO with presence in 20+ countries	-	Japan Asia Investment, SBIC West Japan	48/100
4th	Aster Insights 2006, Tampa (United States), Series C	Provider of contract based oncology clinical trial services	$75M	Clayton Dubilier & Rice, Hearst & 6 others	45/100
5th	Oncotherapeutics 1988, West Hollywood (United States), Acquired	CRO focused on community oncology research, improving cancer therapies' clinical utility	$8.3M	Domain Associates, TVM Capital	44/100
6th	Actithera 2021, Cambridge (United States), Series A	Radiopharmaceutical company developing novel radiotherapeutics for the treatment of cancer through its unique medicinal chemistry platform	$80.8M	M Ventures, 4Bio Capital & 7 others	42/100
7th	Medivir 1998, Sweden, Public	Medivir - Science working wonders	-	-	41/100
8th	Vivia Biotech 2007, Tres Cantos (Spain), Series A	Developer of precision medicine test for hematologic cancers	$7.52M	Suanfarma, Clave	39/100
9th	Medelis 2003, Nashville (United States), Acquired	Oncology CRO providing expert clinical trial management for drug development	-	-	39/100
10th	Tharimmune 2023, Bridgewater (United States), Public	Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory, and oncologic conditions	-	Liberty City Ventures, DRW Trading Group ... & 25 others	38/100